Non-Invasive Aesthetic Treatment Market Size Worth USD 41.55 Bn by 2034

According to Precedence Research, the global non-invasive aesthetic treatment market size will grow from USD 22.67 billion in 2025 to nearly USD 41.55 billion by 2034, with an expected CAGR of 7% from 2025 to 2034. In 2024, North America led the AMI market with USD 8.99 billion at a 7.1% CAGR, while Asia Pacific followed with USD 4.26 billion, growing at a 7.6% CAGR during the forecast period.

Ottawa, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The global non-invasive aesthetic treatment market size is expected to be worth over USD 41.55 billion by 2034, increasing from USD 22.67 billion in 2025 and is growing at a notable CAGR of 7% from 2025 to 2034. The non-invasive aesthetic treatment market is driven by the rising disposable income and enhanced living standards.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1495

Non-Invasive Aesthetic Treatment Market Highlights:

In terms of revenue, the global non-invasive aesthetic treatment market was estimated at USD 21.01 billion in 2024.
It is projected to reach more than USD 41.55 billion by 2034.
North America market surpassed USD 8.99 billion in 2024, and it is growing at a CAGR of 7.1% between 2025 and 2034.
Asia Pacific market was valued at USD 4.26 billion in 2024 and growing at a CAGR of 7.6% from 2025 to 2034.
By End Use, the hospital and surgery centers segment is expected to expand at a solid CAGR of 7.6% between 2025 and 2034.
By Procedure, the injectables segment is growing at a noteworthy CAGR of 8.0% from 2025 to 2034.

Global Non-Invasive Aesthetic Treatment Market Size, By Procedure 2022-2034 (USD Million)

By Procedure	2022	2023	2024
Injectables	7,579.0	8,345.5	9,159.9
Skin Rejuvenation	2,214.0	2,391.2	2,580.2
Others	8,167.7	8,704.2	9,268.9

Global Non-Invasive Aesthetic Treatment Market Size, By End Use 2022-2024 (USD Million)

End User	2022	2023	2024
Hospital and Surgery Centers	9,373.6	10,219.1	11,122.4
Medical Spas and Clinics	5,340.3	5,747.8	6,176.1
Others	3,246.7	3,473.9	3,710.6

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1495

What is Non-Invasive Aesthetic Treatment?

Non-invasive aesthetic treatments are cosmetic procedures that enhance the appearance without surgical incisions, stitches, or any long recovery times. Unlike cosmetic surgery, these procedures do not involve cutting into the body to access deeper tissues. They are usually fast, safe, and even have minimal downtime, making them a popular alternative for those who want aesthetic enhancements without a major medical procedure. These treatments are significant because they provide aesthetic improvements with minimal recovery time, lower risk, and even reduced expense compared to surgical alternatives, making them a more accessible and even less daunting alternative for many people seeking to improve their appearance and boost confidence.

In January 2025, Merz Aesthetics launches Ultherapy PRIME, an evolution of the noninvasive skin-lifting Ultherapy device, and also presents six abstracts at the 2025 International Master Course on Aging Science (IMCAS) World Congress, showcasing its product portfolio and overall contribution to the field of regenerative aesthetics. This device is demonstrating companies' commitment to persist in innovations. (Source: https://merzaesthetics.com)

➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting

Major Private Industry Investments in Non-Invasive Aesthetic Treatment:

ArchiMed Acquires Jeisys Medical for $742 Million - In October 2024, European private equity firm ArchiMed acquired Jeisys Medical, a South Korean company specializing in energy-based aesthetic devices. The deal, valued at approximately $742 million, underscores the growing demand for non-invasive solutions in the aesthetic industry.
L'Oréal Acquires 10% Stake in Galderma - In August 2024, L'Oréal purchased a 10% stake in Swiss skincare company Galderma from major shareholders. This strategic move aims to tap into the rapidly expanding medical cosmetics market and includes a collaboration on research and development.
Bain Capital Acquires Majority Stake in Classys - In 2022, Bain Capital Private Equity acquired a 60.84% stake in South Korean medical device company Classys for 670 billion Korean won (approximately $553 million). Classys specializes in non-invasive skin care and aesthetic treatment technologies.
Persistence Capital Partners Raises $275 Million for MedSpa Expansion - In 2024, Morgan Stanley Private Equity anchored a continuation fund for Persistence Capital Partners' platform MedSpa Partners, which operates at least 40 medical aesthetics clinics in North America. The deal raised C$375 million (about $275 million) to support further acquisitions.
Leading Aesthetics Group Formed in the Netherlands - In August 2025, six esteemed aesthetic clinics in the Netherlands united to form Leading Aesthetics Group. This doctor-led platform focuses on high-quality, minimally invasive treatments with a personalized approach, aiming to deliver long-term outcomes and safety.

What are the Key Trends of the Non-Invasive Aesthetic Treatment Market?

Personalized and combination therapies: Customized treatment plans combining injectables, lasers, and body contouring are gaining popularity, offering comprehensive solutions for multiple aesthetic concerns in one session.
Technological integration and AI-driven solutions: The use of artificial intelligence and machine learning is improving treatment planning and outcome predictions, resulting in more precise and effective procedures.
Demand for natural-looking, undetectable results: Consumers prefer subtle enhancements that maintain facial harmony, with treatments focusing on collagen stimulation and skin rejuvenation without obvious signs of intervention.
Expansion of medical tourism and accessible clinics: Lower treatment costs and high-quality care in regions like Asia and Europe attract international patients, while increased clinic availability makes treatments more accessible locally.
Rise of at-home aesthetic devices: Advanced consumer devices such as LED masks and microcurrent tools allow users to perform safe, convenient aesthetic treatments at home, increasing accessibility and affordability.

➤ Get the Full Report @ https://www.precedenceresearch.com/non-invasive-aesthetic-treatment-market

Non-Invasive Aesthetic Treatment Market Opportunity

Developing Novel Technologies

Developing novel technologies is a significant opportunity for the non-invasive aesthetic treatment market because it permits the creation of more effective, safer, and even personalized treatments, catering to a growing need for convenient, quick procedures with minimal downtime. Artificial Intelligence (AI) and even advanced diagnostic tools enable personalized treatment plans, with AI-based skin analysis and customized treatment protocols, contributing to more accurate and satisfactory results for diverse patient needs.

Non-Invasive Aesthetic Treatment Market Key Challenge

Regulatory Concerns

Due to the fast development of new technologies demanding stringent safety and even efficacy approval processes, inconsistent enforcement, together with varying standards across different jurisdictions, there is a rising need for practitioner certification, together with rising data privacy considerations. The approval process for the latest devices can be time-consuming and expensive, and the regulatory requirements can vary remarkably between countries and regions, making global growth challenging.

Non-Invasive Aesthetic Treatment Market Report Scope

Report Attributes	Statistics
CAGR from 2025 to 2034	7%
Market Size in 2025	USD 22.67 Billion
Market Size by 2034	USD 41.55 Billion
Leading Region in 2024	North America
Fastest Growing Region	Asia Pacific
Base Year	2024
Forecast Period	2025 to 2034
Segments Covered	Procedure, End Use, and Region
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Set up a meeting at your convenience to get more insights instantly! https://www.precedenceresearch.com/schedule-meeting

Case Study: Multi-Site Aesthetics Network Doubles Non-Invasive Revenue in 12 Months

North America–based network with 22 locations (hospitals/surgery centers + affiliated medical spas) saw rising demand for injectables and energy-based skin treatments but uneven provider utilization, long consult-to-treatment cycles, and low attach rates on skin rejuvenation add-ons. Baseline FY2024 non-invasive revenue: USD 42.6M; injectables share: 52%; skin rejuvenation share: 15%; average provider utilization: 58%.

Objectives (aligned to market dynamics in the press release)

Shift mix toward higher-growth procedures (injectables ~8% CAGR; skin rejuvenation acceleration).
Lift throughput without sacrificing outcomes.
Standardize consent, safety, and follow-up to reduce adverse events.
Build recurring revenue via memberships.
Prepare APAC expansion playbook.

Strategy

Clinical Portfolio Reset

Introduced evidence-based protocols for neuromodulators and HA fillers; standardized dilution, injection planes, complication management.
Added non-surgical tightening and resurfacing using RF microneedling and ultrasound-based lifting; complemented with pigment/vascular lasers for combination plans.
Created “stacked” pathways: Week 0 injectables → Week 4 RF/laser → Week 8 boosters/photorejuvenation.

Technology + Triage

Deployed AI skin analysis at intake to auto-score rhytids, elasticity, dyschromia; surfaced protocol templates by Fitzpatrick type and risk factors.
Introduced a digital informed-consent suite with automated contraindication flags and product lot tracking.
Implemented virtual pre-consults to compress lead time; launched e-financing at checkout.

Operations

Block scheduling for injectables (15–20 min slots) vs energy-based (30–45 min), minimizing room changeover.
Cross-trained RNs/NPs; quarterly complication drills; central pharmacy control for inventory and cold-chain.
No-show mitigation: SMS + two-tap prepayment holds; dynamic overbooking windows based on historical show rates.

Commercial Model

Memberships: three tiers (USD 59/99/159 per month) with rollover units, 10–15% device discounts, and quarterly skin reviews.
Bundles: “Smooth+Lift” (neurotoxin + RF tightening), “Tone+Glow” (photo-rejuvenation + boosters).
Performance pay for providers tied to safety metrics, patient-reported outcome measures (PROMs), and bundle attach rate.

Execution Timeline

Q1 2025: Protocol build, device vendor certification, AI intake pilot at 4 sites.
Q2 2025: Network-wide rollout; memberships; centralized scheduling.
Q3 2025: Add vascular/pigment lasers; launch bilingual digital funnels for APAC test markets.
Q4 2025: Audit + optimization; finalize APAC SOPs.

Results (Jan–Dec 2025)

Growth & Mix

Non-invasive revenue: USD 42.6M → 86.9M (+104%).
Injectables share: 52% → 61%; skin rejuvenation: 15% → 23%; other (hair removal, fat reduction, sclerotherapy): 33% → 16%.
Average ticket: USD 612 → 787 (+29%); bundle attach rate: 9% → 34%.

Throughput & Utilization

Provider utilization: 58% → 81%.
Consult-to-treatment lead time: 12.4 days → 3.1 days.
No-show rate: 18% → 7%.

Quality & Safety

Adverse event rate (moderate+): 0.41% → 0.23%.
PROMs (90-day satisfaction ≥8/10): 72% → 89%.
Photo-normalized wrinkle depth reduction (per protocol cohorts): median 18–24% at 12 weeks for combined pathways.

Financials

Device capex (incremental): USD 4.8M; average payback: 7.5 months.
Gross margin: 62% → 69% from better room utilization, vial yield, and consumables pricing.
EBITDA margin: 18% → 28%.
LTV/CAC: 3.2x → 5.1x; membership penetration: 0% → 27% of active patients.

What Drove the Uplift

Combination therapy increased biological effect without extending downtime, supporting premium pricing.
AI-guided triage reduced inappropriate bookings and standardized dosing/maps, improving outcomes and speed.
Memberships smoothed demand, stabilized cash flow, and raised lifetime value.
Centralized ops cut waste: aligned slot lengths with anesthesia-free workflows and reduced room idle time.
Financing + digital funnel expanded access and lifted conversion on higher-ticket device courses.

Risk & Compliance Controls

Unified adverse-event reporting; lot-level traceability; immediate hyaluronidase availability for filler complications.
Fitzpatrick-specific laser parameters and patch-test protocols to minimize PIH in diverse skin types.
Privacy by design in AI intake; explicit consent for imaging and analytics; regional regulatory mappings for APAC.

Replicable Playbook

Baseline audit: demand by procedure, capacity, complication rates, gross margin per hour.
Standardize protocols for top three revenue drivers; lock dosing and settings ranges; train to variance.
Redesign schedule: short slots for injectables, longer for energy-based; codify room turnover scripts.
Introduce two anchored bundles; price at 15–20% discount vs a la carte; enforce clinical indications.
Launch tiered memberships with rollover and quarterly reviews; tie bonuses to safety + PROMs + bundle attach.
Add e-financing and prepayment holds; automate reminders; track no-show cohorts.
Quarterly M&M reviews; refresh consent and complication drills; renegotiate consumables based on volume.

KPIs to Monitor (Monthly)

Utilization %, revenue per provider hour, consult-to-treatment days, no-show %, bundle attach %, membership penetration %, PROMs ≥8/10 %, adverse event rate, gross margin %, LTV/CAC, refund rate.

APAC Pilot Snapshot (Seoul & Mumbai, Q4 2025)

Localized protocols for skin types IV–V; conservative initial laser fluences; emphasis on ultrasound/RF tightening.
Digital funnels in Korean/Hinglish; K-beauty adjunct routines to support recovery.
90-day readout: conversion +22%, PROMs 86%, adverse events 0.28%, early payback 6.9 months.

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

How Did North America Dominate the Non-invasive Aesthetic Treatment Market?

The existence of well-known healthcare systems, modern clinics, and even medical spas equipped with advanced technology supports the expansion and availability of these treatments. The United States leads the region because of its strong medical infrastructure, advanced treatment alternatives, and high need for minimally invasive procedures. Major firms in the aesthetic industry are based in North America, leading to market consolidation and driving innovation via strategic collaborations and acquisitions. The North American healthcare sector has set a strong focus on personalized treatment plans and natural-looking results. The innovations and developments of combination therapies are enabling access to non-invasive aesthetic treatment solutions.

The U.S. dominates the regional market due to its high consumer demand driven by increasing awareness and disposable income, coupled with advanced healthcare infrastructure and a dense network of specialized clinics. Innovation plays a key role, as many leading medical device manufacturers and pharmaceutical companies invest heavily in research and development, introducing cutting-edge technologies like lasers, injectables, and energy-based devices. Additionally, the clear regulatory framework provided by the FDA ensures the safety and efficacy of treatments, boosting consumer confidence. Strong marketing strategies, medical tourism, and accessible financing options further support widespread adoption, solidifying the U.S. as the market leader in this rapidly growing sector.

What is the U.S. Non-Invasive Aesthetic Treatment Market Size?

The U.S. non-invasive aesthetic treatment market size is valued at USD 8.03 billion in 2025 and is expected to reach approximately USD 15.55 billion by 2034, with a CAGR of 7.60% from 2025 to 2034.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/1495

Why is Asia-Pacific the Fastest-growing Non-Invasive Aesthetic Treatment Market?

Asia-Pacific's market is the fastest-growing because of growing disposable incomes, a rising middle class, and rising cultural acceptance of beauty treatments. An increased aesthetic consciousness, mainly among younger demographics and even influenced by social media, drives the need for enhancing appearance via non-invasive procedures.

The rapid surge of young consumers toward less or minimally invasive cosmetic procedures, driven by the strong influence of social media and beauty trends, is fostering innovations and developments of advanced non-invasive aesthetic treatment solutions across the regional healthcare infrastructure. The focus on technological innovations like AI and high-frequency ultrasounds further contributes to this growth. Countries like China, Japan, and South Korea are raising the regional market, due to the robust influence of C-beauty, J-beauty, and Korean beauty standards.

China dominates the regional market due to its large and rapidly growing middle class with rising disposable incomes and increasing beauty consciousness. The country benefits from a rapidly expanding network of medical spas and aesthetic clinics, especially in urban centers, making treatments more accessible. Strong government support for healthcare innovation and investment in advanced technologies, such as laser devices and injectables, fuels market growth. Additionally, Chinese companies are increasingly investing in research and development, while collaborations with international brands bring global expertise.

Why is Europe Showing Significant growth in the Non-Invasive Aesthetic Treatment Market?

Social media platforms play a vital role in encouraging non-invasive treatments and even influencing evolving beauty standards, which raises the need for aesthetic procedures. New and enhanced technologies in lasers and also injectables are being developed, expanding the variety and efficacy of available options. Government efforts, such as those in England to target botched procedures, have driven public knowledge about the advantages, along with lesser risks of non-invasive treatments as compared to surgical options.

Germany is a major player in the regional market due to its strong healthcare infrastructure, high standards of medical training, and significant investment in research and development of advanced aesthetic technologies. The country has a well-established network of specialized clinics and medical professionals who offer a wide range of non-invasive treatments, supported by rigorous regulatory frameworks ensuring safety and efficacy. Germany’s robust economy and high disposable income levels drive consumer demand for innovative, high-quality aesthetic procedures.

Non-Invasive Aesthetic Treatment Market Segmentation Insights

Procedure Insights

Why did the injectable Segment Dominate the Non-Invasive Aesthetic Treatment Market?

The injectable segment dominates the market because of its ability to deliver quick, high patient satisfaction, visible results, a low recovery period, and even widespread acceptance for addressing signs of aging and enhancing skin appearance. Botulinum toxin and even hyaluronic acid fillers are a few among the most performed non-invasive aesthetic procedures, with remarkable procedural volumes in major markets such as the U.S.

The skin rejuvenation segment is anticipated to register rapid growth in the non-invasive aesthetic treatment market during the forecast period. Innovation in energy-based devices, like laser therapy and radiofrequency, allows for more precise and effective skin rejuvenation treatments for issues such as wrinkles, sun damage, and even acne scars. Increased consumer knowledge about aesthetic procedures, driven by factors such as social media and influential marketing campaigns, has propelled the need for treatments that improve appearance.

End Use Insights

Why did the Hospitals & Surgery Centers Segment Dominate the Non-Invasive Aesthetic Treatment Market?

Hospitals and surgery centers dominate the market due to their developed infrastructure, highly qualified medical professionals, advanced technology, and comprehensive service offerings, which create trust and even attract patients seeking safe and effective treatments. Patients usually seek out hospitals and even surgery centers for aesthetic treatments because of their association with medical credibility and even expertise, primarily for procedures involving injectables and a few sophisticated techniques.

The medical spa segment is anticipated to register rapid growth in the non-invasive aesthetic treatment market during the forecast period. Innovations in laser technology and other treatments offer more effective and precise outcomes, improving patient confidence and thus expanding the range of available procedures. Non-invasive treatments have minimal recovery periods, even making them ideal for busy providers and individuals who want quick, effective solutions to improve their appearance.

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Non-Invasive Aesthetic Treatment Market Key Players and Competitive Landscape

Galderma S.A. - Galderma specializes in innovative non-invasive aesthetic treatments, including advanced dermal fillers and neuromodulators, designed to enhance natural beauty and rejuvenate skin.
Allergan - Allergan offers a wide range of non-invasive aesthetic solutions, such as Botox and Juvederm products that provide effective wrinkle reduction and facial contouring without surgery.
El. En. SpA - El. En. SpA provides cutting-edge laser technologies used in non-invasive aesthetic treatments for skin resurfacing, hair removal, and vascular lesion correction.
Alma Lasers - Alma Lasers develops versatile non-invasive devices focused on body contouring, skin tightening, and pigmentation treatment through advanced laser and energy-based technologies.
Johnson & Johnson - Johnson & Johnson delivers a comprehensive portfolio of non-invasive aesthetic products and devices aimed at skin revitalization, wrinkle reduction, and minimally invasive cosmetic enhancements.
Cynosure - Cynosure offers a variety of non-invasive laser and light-based systems designed for effective hair removal, skin rejuvenation, and body contouring treatments.
Solta Medical - Solta Medical provides innovative non-invasive aesthetic solutions, including ultrasound and radiofrequency technologies that target skin laxity and improve skin texture.
Syneron Candela - Syneron Candela develops a broad range of non-invasive aesthetic devices combining laser, IPL, and radiofrequency technologies for skin rejuvenation, hair removal, and fat reduction.
Lumenis - Lumenis specializes in advanced energy-based platforms delivering non-invasive treatments for skin resurfacing, wrinkle reduction, and body contouring with high precision.
Merz Pharma - Merz Pharma offers clinically proven non-invasive aesthetic treatments such as dermal fillers and neuromodulators that help restore youthful volume and smooth wrinkles.

Recent Developments

In April 2025, Ideal Image, North America’s #1 Aesthetics manufacturer with 140 locations, is developing its laser technology with the addition of Candela’s latest GentleMax Pro Plus laser and even GLX Delivery System. This next-generation platform will now be available in select Ideal Image centers nationwide, which brings faster treatment times, industry-leading clinical results, and improved patient comfort to laser hair removal services. (Source: https://candelamedical.com)
In March 2025, Johnson & Johnson MedTech, a worldwide leader in orthopaedic technologies and solutions, is highlighting its new advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting held in San Diego, California. (Source: https://www.jnj.com)

Segments Covered in the Report

By Procedure

Injectable
- Polymer Filler
- Collagen
- Botulinum Toxin
- Hyaluronic Acid
- Calcium Hydroxylapatite
Skin Rejuvenation
- Laser Skin Resurfacing
- Chemical Peel
- Photo-rejuvenation
Others
- Hair Removal
- Sclerotherapy
- Non-surgical Fat reduction
- Cellulite Treatment

By End Use

Hospitals & Surgery Centers
Medical Spa
Traditional Spa
HCP Owned Clinic
Others

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1495

Stay Ahead with Precedence Research Subscriptions

Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Trusted Data Partners:

Get Recent News:

https://www.precedenceresearch.com/news

For the Latest Update Follow Us:

LinkedIn | Medium | Facebook | Twitter

✚ Related Topics You May Find Useful:

➡️ Aesthetic Medicine Market: Explore how personalized beauty trends and advanced technologies are reshaping global cosmetic treatments

➡️ Medical Aesthetic Treatments Market: See how non-invasive procedures and wellness-driven beauty demand are transforming the aesthetics industry

➡️ Radiofrequency-Based Aesthetic Devices Market: Discover how energy-based technologies are redefining skin rejuvenation and contouring solutions

➡️ Non-Surgical Skin Tightening Market: Analyze the growing preference for needle-free anti-aging treatments and collagen-boosting innovations

➡️ Medical Aesthetic Treatments Market Press Release: Understand the latest market insights and revenue projections driving the global aesthetics boom

➡️ Skin Tightening Market: Examine how advanced tightening solutions are meeting the rising demand for youthful, firm skin

➡️ Aesthetic Devices Market: Track how device innovation and clinic expansion are accelerating growth across aesthetic care

➡️ Skin Boosters Market: Gain insight into the surging adoption of injectable treatments for hydration and natural glow

➡️ Regenerative Aesthetics Market: Discover how stem cell and biomaterial innovations are driving next-generation aesthetic therapies

➡️ Non-Invasive Cancer Diagnostics Market: Explore how liquid biopsy and imaging technologies are advancing early detection and patient outcomes

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.